As markets face significant pressure, certain portfolios tied to strategic commodities, resilient tech, and innovative crypto infrastructure are showing notable resilience. Analysts point to long-term thematic bets that are weathering the current storm.
A partial government shutdown triggers furloughs, the Grammys become a platform for political statements, and nationwide protests over immigration policy unfold amid a severe winter storm's aftermath.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.
With a cash reserve that could last just over a year at its current burn rate, InflaRx faces a critical period to prove its clinical pipeline's value. While management has reined in spending, the company's financial strategy is now under the microscope.
As several prominent stocks test 52-week lows, investors face a critical choice: identify oversold opportunities or steer clear of troubled names. We analyze one company showing signs of a turnaround and two where caution may be warranted.
India's government has reaffirmed its stringent cryptocurrency taxation framework in the latest budget, leaving the controversial 30% levy and 1% transaction tax unchanged, dashing industry hopes for reform and cementing a policy that has already driven billions in trading volume offshore.
The traditional rulebook for dining during economic stress is obsolete. As a K-shaped recovery widens the gap between income groups, fast-food giants are struggling with deep discounts while casual dining chains unexpectedly thrive by redefining value.
While several stocks have posted impressive short-term gains, a closer look reveals a divergence between fleeting catalysts and fundamental strength. We analyze one surging name with a solid foundation and two others where caution may be warranted.
A sharp decline in Bitcoin has dragged the entire cryptocurrency market down with it, underscoring a stubborn reality: despite years of innovation and thousands of new tokens, the sector still moves as one, offering investors little shelter from volatility.
Citing weak network usage and a need to strengthen its economic model, the IP-centric blockchain Story Protocol has pushed back its major token supply unlock by six months to August 2026, aiming to mitigate sell-off risks and buy time for growth.
Iran's Supreme Leader Ali Khamenei has issued a stark warning that any U.S. military action against Tehran would escalate into a regional war, accusing Washington of coveting Iran's energy resources. The warning comes amid heightened tensions and internal unrest following deadly protests.
A senior Iranian official has refuted earlier media claims that the Islamic Revolutionary Guard Corps (IRGC) Navy would conduct live-fire military exercises in the vital Strait of Hormuz this week, calling the reports inaccurate.
The Portuguese government has launched a massive financial aid package, combining loans and direct support, to accelerate recovery from the deadly Storm Kristin which left a trail of destruction across the country last week.
The vital Rafah border crossing between Egypt and the Gaza Strip reopened Sunday for limited passenger traffic, marking a significant shift after more than two years of closure. The move, part of a ceasefire deal, initiates a tightly controlled process allowing medical evacuations and returns, though humanitarian aid flow remains uncertain.
Health and Human Services Secretary Robert F. Kennedy Jr. has publicly addressed the deep divisions within America's most storied political family, following the death of his cousin Tatiana Schlossberg and amidst ongoing policy controversies that have placed him at odds with his relatives.
A recent discounted cash flow analysis suggests D&O Green Technologies Berhad's stock may be significantly undervalued, trading around RM0.60 against a calculated fair value of RM0.89. The semiconductor-focused firm's current valuation presents a notable gap for investors to consider.
As global travel surges past pre-pandemic records, the influx of visitors is straining infrastructure and reshaping communities worldwide. From European protests to quiet American suburbs, the quest for authentic experiences is colliding with local life, fueling a housing crisis and raising a critical question: can cities belong to both residents and tourists?
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
While market gains have been concentrated in a handful of tech giants, a select group of companies across semiconductors, beauty, and banking have delivered consistent, triple-digit returns by mastering the fundamentals of growth, margins, and capital efficiency.
